If the overall RRR is a big number that will mean Apabetalone is a big success but a big number only in either subgroup will likely not diminish the success.

Can you point to where atorvastatin vs rosuvastatin is part of the prespecified analysis. ???

https://clinicaltrials.gov/ct2/show/NCT02586155

And I'm not up to speed on what happened to this?   Are most on rosuvastatin?

BETonMace criteria

* Subjects currently not on high intensity statin therapy could start rosuvastatin at Visit 1 and those currently on therapy besides atorvastatin/rosuvastatin can be switched to rosuvastatin at Visit 1